Current Medicines

For more than 140 years, we have worked tirelessly to develop and deliver trusted medicines that meet real needs. Our growing portfolio of medicines includes treatments in the areas of cardiovascular, diabetes, men’s health, musculoskeletal, neuroscience and oncology.

Australian laws and regulations limit the amount of product information that we can provide to the general public via our website. We encourage patients wishing to obtain more detailed information about a Lilly product that has been prescribed to them, to speak to their healthcare professional.

The product information on this website is intended for Australian residents, if you are looking for our New Zealand products page, please click here.


Adcirca ® (tadalafil)

Cardiovascular – In alliance with Boehringer Ingelheim

Jardiance ® * (empagliflozin)


Taltz ® (ixekizumab)

Olumiant ® (baricitinib)


Humalog ® / Humalog ® Mix25 / Humalog ® Mix50 (insulin lispro) cartridges

Humalog ® / Humalog ® Mix25 / Humalog ® Mix50 (insulin lispro) Kwikpen

Humalog ® (insulin lispro) vials

Humalog ® U200 KwikPen ®

Humulin ® R/ Humulin ® NPH/ Humulin ® 30/70 (biosynthetic human insulin) cartridges

Humulin ® R/Humulin ® NPH/ Humulin ® 30/70 (biosynthetic human insulin) vials

Mounjaro ® (tirzepatide)

Trulicity ® (dulaglutide)

Diabetes – In alliance with Boehringer Ingelheim

Jardiance ® * (empagliflozin)

Jardiamet ® * (empagliflozin / metformin hydrochloride)

Glyxambi ® * (empagliflozin/linagliptin)

* A licensed trademark of Boehringer Ingelheim


Omvoh ® (mirikizumab)^

^Omvoh ® (mirikizumab) is not yet available in Australia.

Men’s Health

Cialis ® (tadalafil)


Evista ® (raloxifene hydrochloride)

Forteo ® (teriparatide of recombinant DNA origin)

Humatrope ® (somatropin)


Cymbalta ® (duloxetine hydrochloride)

Emgality ® (galcanezumab)

Prozac ® (fluoxetine hydrochloride)

Strattera ® (atomoxetine hydrochloride)

Zyprexa ® (olanzapine) – Tablets and Wafers

Zyprexa ® IM (olanzapine) – Injection

Zyprexa ® Relprevv (olanzapine) long acting injectable


Alimta ® (pemetrexed)

Cyramza ® (ramucirumab)

Retevmo ® (selpercatinib)

Verzenio TM (abemaciclib)


Olumiant ® (baricitinib)

Taltz ® (ixekizumab)

PP-MG-AU-0098 01/2024